-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Rocket Pharmaceuticals, Inc. annual Nonoperating Income (Expense) history and growth rate from 2020 to 2022.
- Rocket Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $2.48M.
- Rocket Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.82M, a 66.3% increase from 2020.
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)